Skip Ribbon Commands
Skip to main content
SharePoint
dehaze
Practice Management Program
Primary Care Networks Program Management Office
Toward Optimized Practice
search

Hypercalcemia



Released Date:

1/1/2008

Revised:

5/1/2014

Title:

Laboratory Endocrine Testing Guidelines: Hypercalcemia

Description:

The estimated incidence of hypercalcemia due to primary hyperparathyroidism and due to malignancy are 250 cases per million and 150 cases per million respectively. This guideline recommends tests for the initial endocrine investigation of hypercalcemia.

Target Population:

Patients with signs or symptoms of hypercalcemia

Exclusions:

None specified
  
Short Description
  
  
Hypercalcemia
Laboratory Endocrine Testing Guidelines: Hypercalcemia
Summary
  
Hypercalcemia
Laboratory Endocrine Testing Guidelines: Hypercalcemia
Guideline